1-4 of 4
Jun Xie
Close
Sort by
Journal Articles

Effective Novel Fto Inhibitors Show Potent Anti-Cancer Efficacy and Suppress Drug Resistance

Rui Su, PhD, Lei Dong, PhD, Yangchan Li, Li Han, Min Gao, Mark Wunderlich, MS, Xiaolan Deng, Hongzhi Li, PhD, Lei Gao, Chenying Li, MD, Sean Robison, Brandon Tan, Ying Qing, Xi Qin, Emily Prince, Jun Xie, Hanjun Qin, Yue Huang, Wei Li, Chao Shen, PhD, Jie Sun, PhD, Kulkarni Prakash, Hengyou Weng, PhD, Huilin Huang, PhD, Zhenhua Chen, PhD, Bin Zhang, PhD, Xiwei Wu, PhD, Mark J Olsen, Markus Müschen, MD PhD, Guido Marcucci, MD, Salgia Ravi, Ling Li, PhD, Caiguang Yang, Zejuan Li, MD, James C Mulloy, Minjie Wei, David A Horne, PhD, Jianjun Chen, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 233.
https://doi.org/10.1182/blood-2019-124535
Published: 2019
Journal Articles

Protein Degradation and Resultant Hsp90 Dephosphorylation as An Alternative C-KIT Kinase Inhibition Strategy

Bo Zhang, Haitong Fang, Xiaofen Pan, Jun Xie, Yonglong Chen, Sai-Juan Chen, Guangbiao Zhou, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4361.
https://doi.org/10.1182/blood.V116.21.4361.4361
Published: 2010
Journal Articles

Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo

Guang-Biao Zhou, Hui Kang, Lan Wang, Li Gao, Ping Liu, Jun Xie, Feng-Xiang Zhang, Xiang-Qin Weng, Zhi-Xiang Shen, Jue Chen, Long-Jun Gu, Ming Yan, Dong-Er Zhang, Sai-Juan Chen, Zhen-Yi Wang, Zhu Chen
Journal: Blood
Blood (2006) 109 (8): 3441–3450.
https://doi.org/10.1182/blood-2006-06-032250
Published: 2006
Includes: Supplemental data
Journal Articles

Bortezomib Combined with Harringtonine or Arsenious Acid Induced Apoptosis in HL-60 Cells and Its Mechanism.

Fan Yi Meng, MD, Yun-bi Fu, MD, Qi-xin Sun, MD, Jun Xie, MD, Guang-biao Zhou, MD
Journal: Blood
Blood (2006) 108 (11): 4412.
https://doi.org/10.1182/blood.V108.11.4412.4412
Published: 2006